Karlov A V, Orlova N V, Parfenov A I
Moscow Clinical Research and Practical Center, Moscow Healthcare Department, Moscow, Russia.
Ter Arkh. 2015;87(4):53-57. doi: 10.17116/terarkh201587453-57.
To define the rate and type distribution of dyssynergic defecation (DD) in patients with primary chronic constipation (CC) and to evaluate the efficiency of biofeedback (BFB) therapy.
One hundred and thirty-two 18-to-89-year-old patients treated in the Moscow Clinical Research and Practical Center for primary CC were examined using proctological examination, colonofibroscopy, anorectal manometry (ARM), and the balloon expulsion test.
Different types of DD were identified in 44.69% of the patients. Defecation disorder type 1 was prevalent (in 64.4% of the patients with DD). The positive result of BFB therapy was noted in the patients with DD and fecal incontinence.
The timely detection of functional defecation disorders can recover the lost function of pelvic floor muscles by BFB therapy and exclude the uncontrolled patient use of laxatives.
确定原发性慢性便秘(CC)患者中排便协同失调(DD)的发生率和类型分布,并评估生物反馈(BFB)治疗的效果。
对在莫斯科临床研究与实践中心接受治疗的132例18至89岁原发性CC患者进行直肠检查、结肠镜检查、肛门直肠测压(ARM)和气囊排出试验。
44.69%的患者存在不同类型的DD。排便障碍1型最为常见(占DD患者的64.4%)。DD和大便失禁患者的BFB治疗结果呈阳性。
及时发现功能性排便障碍可通过BFB治疗恢复盆底肌肉丧失的功能,并避免患者无节制地使用泻药。